<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T20:47:38Z</responseDate>
  <request identifier="oai:figshare.com:article/33934524" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33934524</identifier>
        <datestamp>2026-09-22T06:16:56Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Production of MarathonRT and its comparison with commercial reverse transcriptases for tRNA sequencing library preparation</dc:title>
          <dc:creator>Jenni K. Pedor (25072095)</dc:creator>
          <dc:creator>Pavlina Gregorova (9915843)</dc:creator>
          <dc:creator>Matea Radesic (25088228)</dc:creator>
          <dc:creator>L. Peter Sarin (9915849)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Reverse transcription</dc:subject>
          <dc:subject>tRNA-seq</dc:subject>
          <dc:subject>group II intron encoded RT</dc:subject>
          <dc:subject>RNA sequencing library preparation</dc:subject>
          <dc:subject>protein purification</dc:subject>
          <dc:subject>tRNA</dc:subject>
          <dc:subject>enzyme</dc:subject>
          <dc:subject>RNA</dc:subject>
          <dc:description>&lt;p&gt;Over the past decade, groundbreaking discoveries have cemented transfer RNAs (tRNAs) as versatile regulators of translation and cellular function. As tRNA research gains momentum, several high-throughput sequencing methods have emerged for quantitative analysis of tRNA isoacceptors in cells. However, the strong secondary structure and rich post-transcriptional modification of most tRNA molecules pose significant challenges for reverse transcriptases, thus hampering library preparation and introducing quantification biases. Current approaches rely on processive next generation reverse transcriptases (ngRTs) – they successfully overcome these problems, albeit with the potential caveat of high experimental costs. Here, we introduce a recombinant MarathonRT (MRT) protein with a C-terminal chitin binding domain (CBD), for which we present a simple and robust one-step purification protocol that yields over 18,000 enzymatic reactions per 0.5 L of expression culture. We also developed an affordable colorimetry-based method for determining the specific activity of these enzymes. Importantly, we benchmarked our in-house produced MRT-CBD using the mim-tRNAseq workflow and show that its performance matches that of commercially available ngRTs. In addition, we implemented the use of a rapid tRNA spin column-based enrichment method for tRNA-seq and LC-MS applications, establishing it as a viable alternative to conventional gel-extraction. Combined, we provide an easily implementable MarathonRT purification protocol along with an improved workflow that significantly reduces the time and cost of tRNA-seq library preparation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T06:16:56Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.33934524.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Production_of_MarathonRT_and_its_comparison_with_commercial_reverse_transcriptases_for_tRNA_sequencing_library_preparation/33934524</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
